跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,716 条关于
“complement protein C3”
全部
13,716
临床试验
5,974
药物
1,293
机构
55
资讯
6,394
7个月前
Novartis Reports Positive Phase III Results for Fabhalta in Rare Kidney Disease C3 Glomerulopathy
上个月
Ancient Immune Protein C3 Boosts Cancer Immunotherapy When Produced Inside Tumors
去年
CDSCO Approves Novartis' Protocol Amendment for Iptacopan Study in Rare Kidney Disorders
11个月前
Biotech Venture Funding Surges 70.9% in Q3 2025, Signaling Market Recovery
去年
Arrowhead's ARO-C3 Shows Promising Results in IgA Nephropathy Trial with 89% Reduction in C3 Levels
前天
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
去年
Fabhalta (Iptacopan) Shows Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Fabhalta Demonstrates Sustained Efficacy in C3 Glomerulopathy Patients at One Year
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
上个月
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
第 1 页,共 640 页
上一页
下一页